Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2009-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archophthalmol.2009.198PMID 19752426PMCID PMC6500457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2.

  2008cited by this paper
• The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.

  2007cited by this paper
• Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration.

  2007cited by this paper
• ISSUES IN QUANTIFYING ATROPHIC MACULAR DISEASE USING RETINAL AUTOFLUORESCENCE

  2006cited by this paper
• DESIGNING CLINICAL TRIALS FOR AGE-RELATED GEOGRAPHIC ATROPHY OF THE MACULA: Enrollment Data From the Geographic Atrophy Natural History Study

  2006cited by this paper
• Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD.

  2006cited by this paper
• Modelling the Natural History of Geographic Atrophy in Patients with Age-Related Macular Degeneration

  2005cited by this paper
• Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.

  2005cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration.

  2004cited by this paper
• Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy.

  2004cited by this paper
• Symmetry of bilateral lesions in geographic atrophy in patients with age-related macular degeneration.

  2002cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

  1999cited by this paper
• The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration.

  1999cited by this paper
• Measuring agreement in method comparison studies

  1999cited by this paper
• Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.

  1999cited by this paper
• Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity.

  1997cited by this paper
• Retinal sensitivity over drusen and nondrusen areas. A study using fundus perimetry.

  1988cited by this paper
• Evolution of geographic atrophy of the retinal pigment epithelium

  1988cited by this paper
• Peripheral retinal function in age-related macular degeneration.

  1985cited by this paper
• Pathologic Features of Senile Macular Degeneration

  1985cited by this paper
• Peripheral retinal function in age-related macular degeneration.

  1985cited by this paper
• Geographic atrophy of the retinal pigment epithelium: diagnosis and vision rehabilitation.

  1981cited by this paper
• Geographic atrophy of the retinal pigment epithelium: diagnosis and vision rehabilitation.

  1981cited by this paper

• Geographic atrophy in age-related macular degeneration: phenotypic characterisation for clinical trial consideration.

  2026cites this paper
• Risk Factors and Quality of Life in Patients With Geographic Atrophy, a Late Stage of Age-Related Macular Degeneration: Findings From the Korea National Health and Nutrition Examination Survey

  2026cites this paper
• Outer Retinal Tubulation and Geographic Atrophy: A Natural History Analysis of Sham Observed Eyes from the OAKS and DERBY Trials

  2025cites this paper
• Modifiable Lifestyle Risk Factors and Strategies for Slowing the Progression of Age-Related Macular Degeneration

  2025influential citation
• Topographic Progression of Geographic Atrophy and Visual Acuity in Nonexudative Age-Related Macular Degeneration

  2025cites this paper
• Suppression of choroidal neovascularization by nonviral gene transfer of pigment epithelium-derived factor.

  2025cites this paper
• Geographic atrophy and factors associated with disease progression among Medicare Advantage enrollees.

  2025cites this paper
• Dual-branch image projection network for geographic atrophy segmentation in retinal OCT images

  2025cites this paper
• Longitudinal Study of Macular Preservation and Geographic Atrophy Progression in Age-Related Eye Disease Study 2

  2025cites this paper
• Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration

  2025cites this paper
• Relationships Between Diet and Geographic Atrophy Progression in the Age-Related Eye Diseases Studies 1 and 2

  2025cites this paper
• Annual prevalence of geographic atrophy and wet age-related macular degeneration among Medicare Advantage enrollees in a US health plan.

  2025cites this paper
• Unveiling the drivers of geographic atrophy progression in eyes with reticular pseudodrusen

  2025cites this paper
• Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

  2025cites this paper
• Comorbid Depression and Anxiety Risk in Older Individuals with Geographic Atrophy: A US Claims Data Analysis

  2025cites this paper
• The intersection of mitochondria, lipids, and ferroptosis: a new avenue for dry age-related macular degeneration

  2025cites this paper
• Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial.

  2025cites this paper
• Characteristics of geographic atrophy secondary to age-related macular degeneration in Korean patients

  2025cites this paper
• Quantifying image quality in AOSLO images of photoreceptors

  2024cites this paper
• Estimating Uncertainty of Geographic Atrophy Segmentations with Bayesian Deep Learning

  2024cites this paper
• Machine Learning for Extraction of Image Features Associated with Progression of Geographic Atrophy

  2024cites this paper
• Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.

  2024cites this paper
• OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD

  2024influential citation
• Combination of optical coherence tomography-derived shape and texture features are associated with development of sub-foveal geographic atrophy in dry AMD

  2024cites this paper
• Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go.

  2024cites this paper
• Ophthalmologists’ awareness of geographic atrophy: An Italian survey including 365 participants

  2024cites this paper
• The Complement System as a Therapeutic Target in Retinal Disease

  2024cites this paper
• Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy

  2024influential citation
• Histologic and Immunohistochemical Characterization of GA-Like Pathology in the Rat Subretinal Sodium Iodate Model

  2024influential citation
• Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate.

  2024cites this paper
• Bilateral Involvement of Age-Related Macular Degeneration in South Korea: Findings from the Korea National Health and Nutrition Examination Survey 2017–2020

  2024cites this paper
• Progression rate of macular retinal pigment epithelium atrophy in geographic atrophy and selected inherited retinal dystrophies. A systematic review and meta-analysis.

  2024cites this paper
• Correlation Between Blue Fundus Autofluorescence and SD-OCT Measurements of Geographic Atrophy in Dry Age-Related Macular Degeneration.

  2024cites this paper
• Integrating Machine Learning and Traditional Survival Analysis to Identify Key Predictors of Foveal Involvement in Geographic Atrophy

  2024cites this paper
• Trend and driving factors in burden of age-related macular degeneration in older adults aged 60-89 years: a global analysis over three decades.

  2024cites this paper
• Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham

  2024cites this paper
• Characterizing Patient Perceptions of Living with Geographic Atrophy: The Global Geographic Atrophy Insights Survey

  2024cites this paper
• Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degeneration

  2024cites this paper
• Informing Endpoints for Clinical Trials of Geographic Atrophy

  2024cites this paper
• Avacincaptad pegol in geographic atrophy secondary to age-related macular degeneration: a profile of its use

  2024cites this paper
• AI-based support for optical coherence tomography in age-related macular degeneration

  2024cites this paper
• Vision loss reduction with avacincaptad pegol for geographic atrophy: a 12-month post hoc analysis of the GATHER1 and GATHER2 trials.

  2024cites this paper
• New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors

  2024cites this paper
• Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside

  2024cites this paper
• Gene therapy for geographic atrophy in age-related macular degeneration: current insights

  2024influential citation
• Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-related Macular Degeneration.

  2024cites this paper
• Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel

  2024cites this paper
• Association of Hyperautofluorescence Signals with Geographic Atrophy Progression in the METformin for the MINimization of Geographic Atrophy Progression Trial

  2024cites this paper
• Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration

  2024cites this paper
• Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialists

  2024cites this paper
• An Updated Simplified Severity Scale for Age-Related Macular Degeneration, Incorporating Reticular Pseudodrusen: Age-Related Eye Disease Study Report No. 42.

  2024cites this paper
• Geographic Atrophy in Age-Related Macular Degeneration

  2023cites this paper
• Progression of Geographic Atrophy: Retrospective Analysis of Patients from the IRIS® Registry (Intelligent Research in Sight)

  2023cites this paper
• Novel Fractal-Based Sub-RPE Compartment OCT Radiomics Biomarkers Are Associated With Subfoveal Geographic Atrophy in Dry AMD

  2023cites this paper
• Genetic and molecular biomarkers for geographic atrophy

  2023cites this paper
• Multimodal imaging and deep learning in geographic atrophy secondary to age‐related macular degeneration

  2023influential citation
• Detection of macular atrophy in age-related macular degeneration aided by artificial intelligence

  2023cites this paper
• Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.

  2023cites this paper
• Evaluating the Effects of C3 Inhibition on Geographic Atrophy Progression from Deep-Learning OCT Quantification: A Split-Person Study

  2023cites this paper
• Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial

  2023cites this paper
• Piloting a forced-choice task to elicit treatment preferences in geographic atrophy

  2023cites this paper
• Retinal Pigment Epithelial Abnormality and Choroidal Large Vascular Flow Imbalance Are Associated with Choriocapillaris Flow Deficits in Age-Related Macular Degeneration in Fellow Eyes

  2023cites this paper
• Treatment of geographic atrophy: an update on data related to pegcetacoplan

  2023cites this paper
• Randomized Phase 2b Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-related Macular Degeneration.

  2023cites this paper
• Pegcetacoplan in the treatment of geographic atrophy.

  2023cites this paper
• Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?

  2023cites this paper
• Treating patients with geographic atrophy: are we there yet?

  2023cites this paper
• A Deep-Learning Algorithm to Predict Short-Term Progression to Geographic Atrophy on Spectral-Domain Optical Coherence Tomography

  2023cites this paper
• Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study

  2023cites this paper
• Complement inhibitors for age-related macular degeneration.

  2023cites this paper
• Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness

  2023cites this paper
• LIGHTSITE III

  2023influential citation
• Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

  2023cites this paper
• Imaging Modalities for Dry Macular Degeneration.

  2023cites this paper
• Three-Month Safety and Efficacy Outcomes for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT™)

  2023cites this paper
• Volumetric directional optical coherence tomography.

  2022cites this paper
• Complement Mediators in Development to Treat Age-Related Macular Degeneration

  2022cites this paper
• Retinal Vessel Density in Age-Related Macular Degeneration Patients with Geographic Atrophy

  2022cites this paper
• Diagnosis of age-related macular degeneration

  2022cites this paper
• Future perspectives for treating patients with geographic atrophy

  2022cites this paper
• Deep Learning to Predict Geographic Atrophy Area and Growth Rate from Multi-modal Imaging (90 characters; max 135 characters).

  2022cites this paper
• Exploring acceptability of emerging intravitreal therapies for Geographic Atrophy: a mixed-methods study

  2022cites this paper
• Oculomotor changes following learned use of an eccentric retinal locus.

  2022cites this paper
• Predicting Topographic Disease Progression and Treatment Response of Pegcetacoplan in Geographic Atrophy Quantified by Deep Learning.

  2022cites this paper
• Adherence to a Mediterranean Diet and Geographic Atrophy Enlargement Rate in the Age-Related Eye Disease Study 2: AREDS2 Report 28.

  2022cites this paper
• Relative Leukocyte Telomere Length and Genetic Variants in Telomere-Related Genes and Serum Levels Role in Age-Related Macular Degeneration

  2022cites this paper
• Geographic Atrophy Progression Is Associated With Choriocapillaris Flow Deficits Measured With Optical Coherence Tomographic Angiography

  2021cites this paper
• Narrative review-drug delivery in age-related macular degeneration

  2021cites this paper
• Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept

  2021cites this paper
• Progression of Geographic Atrophy: Epistemic Uncertainties Affecting Mathematical Models and Machine Learning

  2021cites this paper
• The Use of Neuroprotective Agents in Treating Geographic Atrophy

  2021cites this paper
• Intravitreal treatment for geographic atrophy: coming soon to a patient near you?

  2021cites this paper
• Enlargement of Geographic Atrophy From First Diagnosis to End of Life.

  2021cites this paper
• Conversion from Intermediate Age-Related Macular Degeneration to Geographic Atrophy in a Proxima B Subcohort Using a Multimodal Approach

  2021cites this paper
• Model Structure Uncertainty in the Characterization and Growth of Geographic Atrophy

  2021cites this paper
• Associations of systemic health and medication use with the enlargement rate of geographic atrophy in age-related macular degeneration

  2021cites this paper
• Visual acuity and progression of macular atrophy in patients receiving intravitreal anti-VEGF for age-related macular degeneration

  2021cites this paper
• Innate Immunity in Age-Related Macular Degeneration.

  2021cites this paper
• Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration

  2021cites this paper
• Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia

  2021cites this paper